Target intelligence / Profile preview

Bacterial and follicular cellular components in Cutibacterium acnes and skin

Molecular classification
Other
01

Overview

Bacterial and follicular cellular components in Cutibacterium acnes and skin refers to the complex pathological environment of the pilosebaceous unit involved in the development of acne vulgaris. Cutibacterium acnes (formerly Propionibacterium acnes) is a Gram-positive anaerobic bacterium that colonizes the hair follicle, where it interacts with host sebocytes and keratinocytes (Fitz-Gibbon et al., 2013). The bacterium contributes to inflammation by activating the innate immune system, specifically through Toll-like receptor 2 (TLR2) on macrophages and keratinocytes, which triggers the release of pro-inflammatory cytokines like IL-12 and IL-8 (Kim et al., 2002). Follicular components contribute to the disease state through hyperkeratinization and excessive sebum production, creating an anaerobic niche that promotes bacterial proliferation (StatPearls, 2023). Pharmacological interventions target these components collectively using antibiotics to reduce bacterial load, retinoids to normalize cell turnover, and benzoyl peroxide to induce oxidative stress in the bacteria (Zaenglein et al., 2016). Because this entry describes a multi-factorial biological system rather than a single molecular entity or receptor, it is classified as a system-level description rather than a discrete therapeutic target.

Other names
Cutibacterium acnes-host interactionPilosebaceous unit componentsAcne vulgaris pathogenic complexPropionibacterium acnes-follicle complex
02

Mechanism of action

Inhibition of bacterial protein synthesis, modulation of toll-like receptor signaling, reduction of sebum production, and normalization of follicular keratinocyte differentiation.

03

Biological functions

Immune responseInflammationLipid metabolismCell proliferationOther
04

Disease associations

InfectionInflammationOther
05

Safety considerations

Antibiotic resistanceSkin irritation and erythemaTeratogenicity associated with systemic retinoidsPhotosensitivityDisruption of the skin microbiome
06

Interacting drugs

Tetracycline

7 more in the full profile.

07

Biomarkers

C. acnes phylotype distributionSebum excretion rateTLR2 expression levelsIL-1 alpha concentrationFollicular hyperkeratosis markers

Beyond the preview

Go deeper on Bacterial and follicular cellular components in Cutibacterium acnes and skin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial and follicular cellular components in Cutibacterium acnes and skin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call